{"id":256635,"date":"2026-09-18T12:27:33","date_gmt":"2026-09-18T06:57:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=256635"},"modified":"2026-09-18T12:27:33","modified_gmt":"2026-09-18T06:57:33","slug":"why-zydus-lifesciences-ltd-share-price-price-rise-2026-09-18","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-ltd-share-price-price-rise-2026-09-18\/","title":{"rendered":"Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price rises 2.03% as stock gains today"},"content":{"rendered":"
Zydus Lifesciences Ltd. (ZYDUSLIFE)<\/a> share price rose to Rs 1,160.45 today, up 2.03% from the previous close. Market cap was Rs 1,10,224.17 crore.<\/em><\/div>\n

Published:<\/strong> 18 September 2026 at 12:18:33 PM IST<\/p>\n

Zydus Lifesciences Share Price moved higher today, with the stock at Rs 1,160.45, up 2.03% from the previous close of Rs 1,137.35. The company\u2019s market capitalisation stands at Rs 1,10,224.17 crore, placing the move in a large base of listed value. This Zydus Lifesciences Share Price Today update captures the day\u2019s price rise, turnover of Rs 8.29 crore, and the intraday range between Rs 1,148.45 and Rs 1,167.15. The available data confirms the price event, but it does not establish a company-specific catalyst. In that setting, the most useful way to read the move is through verified price action, valuation, sector context and peer comparison. Univest is tracking the stock news today with a focus on how the share price rise fits the company\u2019s financial profile and its position in Healthcare.<\/p>\n

For readers searching Zydus Lifesciences Share Price, Zydus Lifesciences Share Price Today and Zydus Lifesciences Stock News, the key point is simple: the share price rose Rs 23.10 on the day. The open was Rs 1,150.65, the high was Rs 1,167.15 and the low was Rs 1,148.45. That pattern shows a positive session in price terms, while the broader interpretation should stay anchored to the supplied numbers. Univest uses this type of update to separate verified movement from unsupported assumptions. On the available facts, Zydus Lifesciences remains a closely watched stock in news today because the market cap is substantial, the valuation is measurable, and the company can be compared with other pharmaceuticals names on the same benchmark.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n